39 studies found for:    " February 03, 2010":" March 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants
Conditions: HIV-1 Infection;   HIV Infections
Intervention: Biological: PENNVAX-B
2 Completed Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy
Conditions: HIV Infection;   Antiretroviral Side Effects;   Lipodystrophy Syndrome Related to HIV Infection
Intervention: Device: Eutrophill
3 Completed HIV Vaccine Study in HIV Positive Patients
Condition: HIV Infections
Interventions: Biological: HIV-v (Low Dose);   Biological: HIV-v (High Dose);   Biological: HIV-v (Control)
4 Completed A Safety Study of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo
5 Unknown  Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
6 Completed Stocrin Re-examination Study (0831-028)
Condition: HIV Infection
Intervention:
7 Active, not recruiting Alcohol Pharmacotherapy for HIV+ Prisoners
Conditions: Alcohol Dependence;   Problem Drinking;   Hazardous Drinking;   Human Immunodeficiency Virus;   AIDS
Interventions: Drug: Vivitrol- Intramuscular naltrexone (depot-formulation);   Drug: Placebo
8 Completed PENTA Fosamprenavir Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Exposure to licensed dose of FPV (+/- 20% of 18mg/kg BID + RTV)
9 Completed Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
Conditions: Fracture;   Infection, Human Immunodeficiency Virus
Interventions: Other: No Antiretroviral (ARV) Drug Exposure;   Drug: Any Antiretroviral (ARV) Drug Exposure
10 Unknown  Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: DOT-HAART
11 Active, not recruiting Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet
Condition: Human Immunodeficiency Virus
Intervention:
12 Completed
Has Results
Evaluation of Kaletra Therapy Over the Long-term
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
13 Completed
Has Results
Special Investigation of Kaletra in Pregnant Women
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
14 Completed
Has Results
Drug Use Investigation of Kaletra
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
15 Active, not recruiting Kaletra in Combination With Antiretroviral Agents
Condition: Human Immunodeficiency Virus
Intervention:
16 Completed
Has Results
Kaletra: Therapy With Double Protease Inhibitors
Condition: Human Immunodeficiency Virus
Intervention:
17 Completed
Has Results
Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
Condition: Human Immunodeficiency Virus-Infection
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
18 Unknown  Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
19 Unknown  (Men Who Have Sex With Men) MSM Community Intervention Trial
Conditions: HIV;   Syphilis;   Herpesvirus 2, Human
Intervention: Other: behavior intervention and male circumcision
20 Completed Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza
Condition: HIV
Intervention: Biological: Foceteria® (Novartis)

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Indicates status has not been verified in more than two years